2022
DOI: 10.1089/dia.2021.0503
|View full text |Cite
|
Sign up to set email alerts
|

Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
36
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 37 publications
(36 citation statements)
references
References 14 publications
0
36
0
Order By: Relevance
“…In a study by the Wireless Innovation for Seniors With Diabetes Mellitus study group [8], CGM users achieved an adjusted difference of -1.9 percentage points in time below 70mg/dL compared to the standard blood glucose monitoring group. This benefit was sustained after 12 months of CGM use [9].…”
Section: Discussionmentioning
confidence: 86%
See 2 more Smart Citations
“…In a study by the Wireless Innovation for Seniors With Diabetes Mellitus study group [8], CGM users achieved an adjusted difference of -1.9 percentage points in time below 70mg/dL compared to the standard blood glucose monitoring group. This benefit was sustained after 12 months of CGM use [9].…”
Section: Discussionmentioning
confidence: 86%
“…Simpler sensor insertion and app setup processes allow the seventh-generation CGM system to be even easier for older adults to learn and use, which may aid in their motivation to try a new technology [11]. RT-CGM with its alerts and alarms has been shown to contribute to better glycemic outcomes in older adults, including severe hypoglycemia (SH), which is particularly dangerous in this population [8,9]. In a study by the Wireless Innovation for Seniors With Diabetes Mellitus study group [8], CGM users achieved an adjusted difference of -1.9 percentage points in time below 70mg/dL compared to the standard blood glucose monitoring group.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The primary outcome was the time spent in hypo-glycaemia, defined as blood glucose <70 mg/ The authors concluded that CGM should be considered as a standard of care for older adults living with type 1 diabetes, given their hypoglycaemic vulnerability. 32 MOBILE was an 8-month randomized trial that compared the use of CGM with conventional blood glucose monitoring in people living with type 2 diabetes on basal insulin. 33…”
Section: Clinical Studies Of Continuous Glucose Monitoring In Older A...mentioning
confidence: 99%
“…The authors concluded that CGM should be considered as a standard of care for older adults living with type 1 diabetes, given their hypo-glycaemic vulnerability. 32 …”
Section: Clinical Studies Of Continuous Glucose Monitoring In Older A...mentioning
confidence: 99%